Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CorMedix (CRMD) Equity Ratio (2016 - 2025)

Historic Equity Ratio for CorMedix (CRMD) over the last 13 years, with Q3 2025 value amounting to 0.5.

  • CorMedix's Equity Ratio fell 3415.58% to 0.5 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.5, marking a year-over-year decrease of 3415.58%. This contributed to the annual value of 0.71 for FY2024, which is N/A changed from last year.
  • As of Q3 2025, CorMedix's Equity Ratio stood at 0.5, which was down 3415.58% from 0.87 recorded in Q2 2025.
  • In the past 5 years, CorMedix's Equity Ratio ranged from a high of 0.95 in Q1 2021 and a low of 0.5 during Q3 2025
  • Moreover, its 5-year median value for Equity Ratio was 0.9 (2022), whereas its average is 0.85.
  • As far as peak fluctuations go, CorMedix's Equity Ratio soared by 2440.67% in 2021, and later crashed by 3415.58% in 2025.
  • CorMedix's Equity Ratio (Quarter) stood at 0.91 in 2021, then fell by 2.56% to 0.89 in 2022, then rose by 2.54% to 0.91 in 2023, then fell by 21.72% to 0.71 in 2024, then plummeted by 30.05% to 0.5 in 2025.
  • Its last three reported values are 0.5 in Q3 2025, 0.87 for Q2 2025, and 0.77 during Q1 2025.